Autres langues Evolent Health, Inc.

Actions

EVH

US30050B1017

Marché Fermé - Nyse Autres places de cotation 22:00:02 14/05/2024			Varia. 5j.	Varia. 1 janv.
23,85 ^USD	+0,42 %		-13,62 %	-27,79 %

14/05	EVOLENT HEALTH, INC. : Truist Securities conserve son opinion neutre	ZM
10/05	EVOLENT HEALTH, INC. : UBS persiste à l'achat	ZM

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Evolent Health: Q1 Earnings Snapshot	09/05
Evolent Health Q1 Adjusted Earnings, Revenue Rise; Q2 Revenue Guidance Set, 2024 Revenue Outlook Increased	09/05
Earnings Flash (EVH) EVOLENT HEALTH Posts Q1 EPS $0.34, vs. Street Est of $0.30	09/05
Earnings Flash (EVH) EVOLENT HEALTH Posts Q1 Revenue $639.7M, vs. Street Est of $598.9M	09/05
Evolent and Careology form strategic care navigation partnership to enhance cancer care in the U.S.	09/05
Evolent Health, Inc. and Careology Form Strategic Care Navigation Partnership to Enhance Cancer Care in the U.S	09/05
Evolent Announces First Quarter 2024 Results	09/05
Evolent Health, Inc. Provides Earnings Guidance for the Second Quarter Ending June 30, 2024 and Raises Earnings Guidance for the Full Year Full Year Ending December 31, 2024	09/05
Evolent Health : 2024 Notice of Meeting and Proxy Statement	26/04
Evolent Health : 2024 Proxy Card	26/04
Evolent To Release First Quarter 2024 Financial Results on Thursday, May 9, 2024	18/04
Evolent Health Q4 Adjusted Income, Revenue Rise; Q1, 2024 Revenue Guidance Set; Shares Jump After Hours	22/02
Evolent Health: Q4 Earnings Snapshot	22/02
Earnings Flash (EVH) EVOLENT HEALTH Reports Q4 EPS $0.23, vs. Street Est of $0.15	22/02
Earnings Flash (EVH) EVOLENT HEALTH Posts Q4 Revenue $556.1M, vs. Street Est of $542.9M	22/02
Evolent Announces Fourth Quarter and Full Year 2023 Results	22/02
Evolent Health, Inc. Provides Earnings Guidance for the First Quarter Ending March 31, 2024 and Full Year Ending December 31, 2024	22/02
Evolent Health, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	22/02
Evolent Adds Russell Glass, Headspace CEO, to Board of Directors	14/02
Evolent Health, Inc. Announces Board Changes	14/02

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Evolent Health, Inc.

Actions

EVH

US30050B1017

Autres langues

Filtres